SIG Group (SIGN) Q3 2025 TU earnings summary

Executive summary

• Q3 2025 revenue declined due to deteriorating consumer sentiment, customer destocking, and weaker demand across all geographies, with inventory optimization and underperformance in deprioritized segments.

• Strategic review resulted in €320 million non-recurring pre-tax impairment charges, mainly non-cash, with up to €40 million more expected in Q4; cash outflows for severance anticipated in 2026.

• Innovation focus highlighted by the launch of next-generation aseptic spouted pouch system and successful recycling trial of 85% paper-content carton.

• Despite market challenges, 60–70 filler placements are expected in 2025, but this will not offset lower capacity utilization.

• Net income for Q3 2025 was a loss of €221.8 million, compared to a profit of €45.2 million in Q3 2024.

Financial highlights

• Q3 2025 revenue was €769 million, down 6.7% reported and 3.9% at constant currency year-over-year; nine-month revenue was €2,347.5 million, down 2.1% reported.

• Adjusted EBITDA for Q3 was €123 million (16% margin); excluding non-recurring charges, €184 million (24% margin).

• Adjusted net income for Q3 was €17 million, or €61 million excluding non-recurring charges.

• Free cash flow for Q3 was €55 million, down from €78 million in Q3 2024; nine-month free cash flow was negative €84.4 million.

• Net capital expenditure for nine months was €168.9 million, about 7% of revenue, consistent with prior year.

Outlook and guidance

• 2025 full-year guidance expects flat to slightly negative revenue growth at constant currency and constant resin.

• Adjusted EBITDA margin for 2025 expected around 21% including non-recurring charges, 24–24.5% excluding them.

• Cash dividend for 2025 proposed to be paused to prioritize capital discipline and deleveraging.

• Guidance subject to input cost and forex volatility; first view on 2026 guidance to be provided at upcoming investor update.